RAC 2.92% $1.94 race oncology ltd

Ann: MD Anderson Preclinical AML Study on Zantrene Published, page-42

  1. 13,155 Posts.
    lightbulb Created with Sketch. 1272
    Anyway, RAC is in a down trend and the news pumps like this won't have the same impact any more now the hype train has come off RAC and the sector. It needs definite and absolute trial results for all the trials listed above in the link. That will be the only thing that can arrest the slide.
 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.